| 0 |
PROPHYLAXIS AGAINST TRANSPLANT REJECTION |
103 |
1.0000 |
| 1 |
NEW ONSET DIABETES AFTER TRANSPLANTATION |
168 |
0.9711 |
| 2 |
TRANSPLANTATION ASSOCIATED FOOD ALLERGY |
96 |
0.9505 |
| 3 |
MALACOPLAKIA |
404 |
0.8821 |
| 4 |
RENAL GRAFT INFECTION |
197 |
0.8491 |
| 5 |
POST TRANSPLANT DISTAL LIMB SYNDROME |
167 |
0.8227 |
| 6 |
TRICHODYSPLASIA SPINULOSA |
310 |
0.8136 |
| 7 |
SMOOTH MUSCLE CELL NEOPLASM |
339 |
0.8110 |
| 8 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
1861 |
0.7936 |
| 9 |
PHAEOHYPHOMYCOSIS |
376 |
0.7850 |
| 10 |
DELAYED GRAFT FUNCTION |
546 |
0.7679 |
| 11 |
PANCREAS TRANSPLANT REJECTION |
149 |
0.7413 |
| 12 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
2437 |
0.7371 |
| 13 |
TRANSPLANT DYSFUNCTION |
1279 |
0.7161 |
| 14 |
CHRONIC ALLOGRAFT NEPHROPATHY |
544 |
0.6948 |
| 15 |
POLYOMAVIRUS VIRAEMIA |
737 |
0.6940 |
| 16 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
806 |
0.6717 |
| 17 |
DONOR SPECIFIC ANTIBODY PRESENT |
102 |
0.6623 |
| 18 |
ALTERNARIA INFECTION |
243 |
0.6532 |
| 19 |
RHODOCOCCUS INFECTION |
108 |
0.6506 |
| 20 |
TRANSPLANT REJECTION |
5112 |
0.6375 |
| 21 |
LIVER TRANSPLANT REJECTION |
1108 |
0.6162 |
| 22 |
RENAL TRANSPLANT FAILURE |
607 |
0.6144 |
| 23 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
3126 |
0.6135 |
| 24 |
PARVOVIRUS B19 INFECTION |
543 |
0.6067 |
| 25 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
1377 |
0.6066 |
| 26 |
HEART TRANSPLANT REJECTION |
623 |
0.6002 |
| 27 |
HUMAN POLYOMAVIRUS INFECTION |
312 |
0.5876 |
| 28 |
LUNG TRANSPLANT REJECTION |
368 |
0.5576 |
| 29 |
HUMAN HERPESVIRUS 8 INFECTION |
332 |
0.5452 |
| 30 |
CEREBRAL NOCARDIOSIS |
124 |
0.5322 |
| 31 |
PULMONARY NOCARDIOSIS |
435 |
0.5279 |
| 32 |
ACANTHAMOEBA INFECTION |
96 |
0.5106 |
| 33 |
GRAFT LOSS |
357 |
0.4924 |
| 34 |
COMPLICATIONS OF TRANSPLANTED LUNG |
151 |
0.4919 |
| 35 |
KIDNEY TRANSPLANT REJECTION |
2343 |
0.4878 |
| 36 |
BK VIRUS INFECTION |
1584 |
0.4692 |
| 37 |
PULMONARY MUCORMYCOSIS |
247 |
0.4678 |
| 38 |
COMPLICATIONS OF TRANSPLANTED HEART |
100 |
0.4651 |
| 39 |
DISSEMINATED MUCORMYCOSIS |
183 |
0.4645 |
| 40 |
HUMAN EHRLICHIOSIS |
97 |
0.4641 |
| 41 |
EPSTEIN-BARR VIRAEMIA |
509 |
0.4590 |
| 42 |
BLASTOMYCOSIS |
216 |
0.4444 |
| 43 |
CYTOMEGALOVIRUS VIRAEMIA |
1933 |
0.4341 |
| 44 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
104 |
0.4245 |
| 45 |
CRYPTOSPORIDIOSIS INFECTION |
222 |
0.4229 |
| 46 |
COMPLICATIONS OF TRANSPLANTED LIVER |
150 |
0.4167 |
| 47 |
MONKEYPOX |
115 |
0.4167 |
| 48 |
SCEDOSPORIUM INFECTION |
288 |
0.4079 |
| 49 |
NOCARDIOSIS |
1001 |
0.3910 |
| 50 |
MICROSPORIDIA INFECTION |
136 |
0.3875 |
| 51 |
DERMATOPHYTOSIS |
110 |
0.3873 |
| 52 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
356 |
0.3844 |
| 53 |
HEPATIC ARTERY THROMBOSIS |
112 |
0.3823 |
| 54 |
TRANSPLANT FAILURE |
909 |
0.3704 |
| 55 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
101 |
0.3556 |
| 56 |
RENAL TUBULAR ATROPHY |
313 |
0.3549 |
| 57 |
VIRAL HAEMORRHAGIC CYSTITIS |
252 |
0.3539 |
| 58 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
977 |
0.3531 |
| 59 |
MYCOBACTERIUM HAEMOPHILUM INFECTION |
100 |
0.3497 |
| 60 |
WEST NILE VIRAL INFECTION |
262 |
0.3493 |
| 61 |
CYTOMEGALOVIRUS ENTERITIS |
124 |
0.3483 |
| 62 |
GRAFT VERSUS HOST DISEASE IN SKIN |
764 |
0.3465 |
| 63 |
ACUTE GRAFT VERSUS HOST DISEASE |
1582 |
0.3453 |
| 64 |
GRAFT VERSUS HOST DISEASE IN LUNG |
165 |
0.3452 |
| 65 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
102 |
0.3423 |
| 66 |
CYSTITIS VIRAL |
131 |
0.3420 |
| 67 |
CHRONIC GRAFT VERSUS HOST DISEASE |
1206 |
0.3337 |
| 68 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
121 |
0.3324 |
| 69 |
IDIOPATHIC PNEUMONIA SYNDROME |
99 |
0.3322 |
| 70 |
ADENOVIRUS INFECTION |
956 |
0.3293 |
| 71 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
701 |
0.3291 |
| 72 |
UREAPLASMA INFECTION |
133 |
0.3260 |
| 73 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
459 |
0.3248 |
| 74 |
DISSEMINATED CRYPTOCOCCOSIS |
242 |
0.3197 |
| 75 |
RENAL TUBULAR INJURY |
386 |
0.3177 |
| 76 |
MUCORMYCOSIS |
821 |
0.3156 |
| 77 |
LYMPHOCELE |
209 |
0.3148 |
| 78 |
CAT SCRATCH DISEASE |
126 |
0.3134 |
| 79 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
499 |
0.3113 |
| 80 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
222 |
0.3088 |
| 81 |
INFECTION REACTIVATION |
352 |
0.3074 |
| 82 |
THROMBOTIC MICROANGIOPATHY |
2989 |
0.3064 |
| 83 |
ALVEOLAR PROTEINOSIS |
180 |
0.3041 |
| 84 |
CRYPTOCOCCOSIS |
485 |
0.2974 |
| 85 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
387 |
0.2938 |
| 86 |
CYTOMEGALOVIRUS OESOPHAGITIS |
107 |
0.2908 |
| 87 |
KIDNEY FIBROSIS |
501 |
0.2886 |
| 88 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
507 |
0.2866 |
| 89 |
CYTOMEGALOVIRUS INFECTION |
4728 |
0.2842 |
| 90 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1249 |
0.2825 |
| 91 |
EPSTEIN-BARR VIRUS INFECTION |
1705 |
0.2726 |
| 92 |
GRAFT VERSUS HOST DISEASE IN LIVER |
195 |
0.2723 |
| 93 |
SYSTEMIC MYCOSIS |
315 |
0.2697 |
| 94 |
ENGRAFTMENT SYNDROME |
158 |
0.2673 |
| 95 |
HEPATITIS E |
419 |
0.2652 |
| 96 |
GRAFT VERSUS HOST DISEASE |
1855 |
0.2577 |
| 97 |
COMPLICATIONS OF TRANSPLANT SURGERY |
130 |
0.2574 |
| 98 |
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME |
206 |
0.2534 |
| 99 |
STRONGYLOIDIASIS |
407 |
0.2517 |
| 100 |
HISTOPLASMOSIS DISSEMINATED |
396 |
0.2494 |
| 101 |
GRAFT COMPLICATION |
144 |
0.2453 |
| 102 |
VIRAEMIA |
338 |
0.2439 |
| 103 |
STENOTROPHOMONAS INFECTION |
329 |
0.2424 |
| 104 |
MENINGITIS CRYPTOCOCCAL |
422 |
0.2411 |
| 105 |
TOXOPLASMOSIS |
260 |
0.2407 |
| 106 |
PNEUMONIA CYTOMEGALOVIRAL |
465 |
0.2392 |
| 107 |
CYTOMEGALOVIRUS COLITIS |
548 |
0.2381 |
| 108 |
CEREBRAL ASPERGILLOSIS |
146 |
0.2374 |
| 109 |
JC VIRUS INFECTION |
377 |
0.2356 |
| 110 |
CYTOMEGALOVIRUS TEST POSITIVE |
404 |
0.2265 |
| 111 |
GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE |
116 |
0.2214 |
| 112 |
INFECTIVE ANEURYSM |
109 |
0.2202 |
| 113 |
DISSEMINATED ASPERGILLOSIS |
103 |
0.2182 |
| 114 |
GLOMERULOSCLEROSIS |
137 |
0.2168 |
| 115 |
MYCOBACTERIUM ABSCESSUS INFECTION |
154 |
0.2154 |
| 116 |
ANGIOSARCOMA |
99 |
0.2148 |
| 117 |
CORYNEBACTERIUM INFECTION |
114 |
0.2131 |
| 118 |
LOCKED-IN SYNDROME |
98 |
0.2126 |
| 119 |
ASPERGILLUS INFECTION |
1392 |
0.2119 |
| 120 |
PNEUMONIA CRYPTOCOCCAL |
199 |
0.2106 |
| 121 |
HUMAN HERPESVIRUS 6 INFECTION |
393 |
0.2077 |
| 122 |
DRUG LEVEL FLUCTUATING |
184 |
0.2072 |
| 123 |
PNEUMOCYSTIS JIROVECII INFECTION |
245 |
0.2050 |
| 124 |
BRAIN ABSCESS |
519 |
0.2049 |
| 125 |
KLEBSIELLA INFECTION |
1034 |
0.2043 |
| 126 |
ENTEROCOCCAL INFECTION |
984 |
0.2034 |
| 127 |
EPSTEIN-BARR VIRUS TEST POSITIVE |
127 |
0.2013 |
| 128 |
KLEBSIELLA BACTERAEMIA |
189 |
0.1989 |
| 129 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
142 |
0.1978 |
| 130 |
VARICELLA ZOSTER VIRUS INFECTION |
407 |
0.1961 |
| 131 |
URETERIC STENOSIS |
156 |
0.1948 |
| 132 |
CEREBRAL TOXOPLASMOSIS |
180 |
0.1927 |
| 133 |
OSMOTIC DEMYELINATION SYNDROME |
142 |
0.1924 |
| 134 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
148 |
0.1878 |
| 135 |
BRONCHOPULMONARY ASPERGILLOSIS |
1420 |
0.1830 |
| 136 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
108 |
0.1827 |
| 137 |
FUSARIUM INFECTION |
127 |
0.1814 |
| 138 |
MYCOPLASMA INFECTION |
139 |
0.1780 |
| 139 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
133 |
0.1727 |
| 140 |
ACINETOBACTER INFECTION |
188 |
0.1717 |
| 141 |
OBLITERATIVE BRONCHIOLITIS |
225 |
0.1714 |
| 142 |
VISCERAL LEISHMANIASIS |
121 |
0.1676 |
| 143 |
ENTEROBACTER INFECTION |
275 |
0.1635 |
| 144 |
ENCEPHALITIS VIRAL |
199 |
0.1634 |
| 145 |
ENTEROCOCCAL SEPSIS |
131 |
0.1617 |
| 146 |
SECONDARY IMMUNODEFICIENCY |
191 |
0.1572 |
| 147 |
GASTROENTERITIS NOROVIRUS |
207 |
0.1558 |
| 148 |
HISTOPLASMOSIS |
275 |
0.1552 |
| 149 |
PNEUMONIA PSEUDOMONAL |
231 |
0.1505 |
| 150 |
ENTEROVIRUS INFECTION |
130 |
0.1505 |
| 151 |
PNEUMATOSIS INTESTINALIS |
428 |
0.1499 |
| 152 |
HAEMOLYTIC URAEMIC SYNDROME |
346 |
0.1491 |
| 153 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1410 |
0.1476 |
| 154 |
ENTEROCOCCAL BACTERAEMIA |
152 |
0.1434 |
| 155 |
MYCOBACTERIAL INFECTION |
246 |
0.1427 |
| 156 |
RENAL TRANSPLANT |
512 |
0.1416 |
| 157 |
APLASIA PURE RED CELL |
485 |
0.1408 |
| 158 |
NOROVIRUS INFECTION |
200 |
0.1385 |
| 159 |
VENOOCCLUSIVE LIVER DISEASE |
671 |
0.1357 |
| 160 |
IGA NEPHROPATHY |
223 |
0.1343 |
| 161 |
CYSTITIS HAEMORRHAGIC |
541 |
0.1341 |
| 162 |
PROTEUS INFECTION |
96 |
0.1337 |
| 163 |
PNEUMONIA KLEBSIELLA |
243 |
0.1321 |
| 164 |
NEPHROPATHY TOXIC |
1467 |
0.1306 |
| 165 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1298 |
0.1291 |
| 166 |
HERPES ZOSTER DISSEMINATED |
103 |
0.1283 |
| 167 |
ACTINIC KERATOSIS |
332 |
0.1278 |
| 168 |
RENAL ARTERY STENOSIS |
173 |
0.1255 |
| 169 |
PSEUDOMONAS INFECTION |
1076 |
0.1253 |
| 170 |
SUPERINFECTION BACTERIAL |
99 |
0.1248 |
| 171 |
CYTOMEGALOVIRUS CHORIORETINITIS |
242 |
0.1240 |
| 172 |
URINARY TRACT INFECTION ENTEROCOCCAL |
115 |
0.1231 |
| 173 |
BILE DUCT STENOSIS |
147 |
0.1226 |
| 174 |
ANOGENITAL WARTS |
109 |
0.1222 |
| 175 |
LYMPHOPROLIFERATIVE DISORDER |
357 |
0.1214 |
| 176 |
ESCHERICHIA INFECTION |
983 |
0.1194 |
| 177 |
ASPERGILLOSIS |
156 |
0.1194 |
| 178 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
249 |
0.1159 |
| 179 |
FUNGAL SEPSIS |
96 |
0.1155 |
| 180 |
SYSTEMIC CANDIDA |
288 |
0.1146 |
| 181 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
841 |
0.1120 |
| 182 |
GLOMERULONEPHRITIS MEMBRANOUS |
131 |
0.1114 |
| 183 |
DRUG LEVEL INCREASED |
1844 |
0.1113 |
| 184 |
VACCINATION FAILURE |
184 |
0.1106 |
| 185 |
ATYPICAL MYCOBACTERIAL INFECTION |
156 |
0.1102 |
| 186 |
KLEBSIELLA SEPSIS |
124 |
0.1100 |
| 187 |
INFECTIOUS PLEURAL EFFUSION |
167 |
0.1097 |
| 188 |
GINGIVAL HYPERTROPHY |
163 |
0.1074 |
| 189 |
LUPUS NEPHRITIS |
200 |
0.1068 |
| 190 |
DIFFUSE LARGE B-CELL LYMPHOMA |
823 |
0.1067 |
| 191 |
RENAL TUBULAR ACIDOSIS |
233 |
0.1067 |
| 192 |
GLOMERULONEPHRITIS |
260 |
0.1061 |
| 193 |
CENTRAL NERVOUS SYSTEM INFECTION |
121 |
0.1056 |
| 194 |
HYPERTROPHIC CARDIOMYOPATHY |
163 |
0.1052 |
| 195 |
ESCHERICHIA BACTERAEMIA |
247 |
0.1050 |
| 196 |
PAPILLOMA VIRAL INFECTION |
173 |
0.1048 |
| 197 |
TRANSITIONAL CELL CARCINOMA |
136 |
0.1048 |
| 198 |
ILEAL ULCER |
106 |
0.1047 |
| 199 |
NEUROENDOCRINE CARCINOMA OF THE SKIN |
101 |
0.1032 |
| 200 |
PYELONEPHRITIS ACUTE |
200 |
0.1019 |
| 201 |
PNEUMONIA FUNGAL |
400 |
0.1013 |
| 202 |
PNEUMOMEDIASTINUM |
178 |
0.0984 |
| 203 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
135 |
0.0979 |
| 204 |
STEROID DIABETES |
146 |
0.0973 |
| 205 |
SQUAMOUS CELL CARCINOMA OF SKIN |
587 |
0.0971 |
| 206 |
DIFFUSE ALVEOLAR DAMAGE |
109 |
0.0948 |
| 207 |
VENOOCCLUSIVE DISEASE |
236 |
0.0942 |
| 208 |
BACTERIAL SEPSIS |
303 |
0.0929 |
| 209 |
RENAL TUBULAR NECROSIS |
902 |
0.0919 |
| 210 |
PARAINFLUENZAE VIRUS INFECTION |
139 |
0.0913 |
| 211 |
DISSEMINATED TUBERCULOSIS |
230 |
0.0896 |
| 212 |
HISTIOCYTOSIS HAEMATOPHAGIC |
266 |
0.0895 |
| 213 |
FUNGAEMIA |
139 |
0.0883 |
| 214 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2451 |
0.0864 |
| 215 |
HYPOGAMMAGLOBULINAEMIA |
567 |
0.0862 |
| 216 |
URINARY TRACT INFECTION BACTERIAL |
213 |
0.0842 |
| 217 |
FUNGAL SKIN INFECTION |
333 |
0.0824 |
| 218 |
DRUG LEVEL ABOVE THERAPEUTIC |
367 |
0.0800 |
| 219 |
BACTERAEMIA |
939 |
0.0790 |
| 220 |
HERPES SIMPLEX |
514 |
0.0790 |
| 221 |
ESCHERICHIA URINARY TRACT INFECTION |
335 |
0.0787 |
| 222 |
LIVER TRANSPLANT |
286 |
0.0786 |
| 223 |
NORMOCYTIC ANAEMIA |
115 |
0.0782 |
| 224 |
OPPORTUNISTIC INFECTION |
143 |
0.0773 |
| 225 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
206 |
0.0767 |
| 226 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
201 |
0.0755 |
| 227 |
ORGANISING PNEUMONIA |
368 |
0.0742 |
| 228 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
145 |
0.0734 |
| 229 |
STAPHYLOCOCCAL BACTERAEMIA |
310 |
0.0712 |
| 230 |
LOW BIRTH WEIGHT BABY |
558 |
0.0702 |
| 231 |
PYELONEPHRITIS |
608 |
0.0701 |
| 232 |
LUNG CONSOLIDATION |
194 |
0.0693 |
| 233 |
PNEUMOPERITONEUM |
128 |
0.0692 |
| 234 |
PNEUMONIA PNEUMOCOCCAL |
102 |
0.0688 |
| 235 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1191 |
0.0673 |
| 236 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
554 |
0.0671 |
| 237 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
332 |
0.0666 |
| 238 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
228 |
0.0665 |
| 239 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
148 |
0.0664 |
| 240 |
PNEUMONIA STAPHYLOCOCCAL |
131 |
0.0663 |
| 241 |
HYPERPARATHYROIDISM SECONDARY |
165 |
0.0658 |
| 242 |
ESCHERICHIA SEPSIS |
190 |
0.0655 |
| 243 |
PSEUDOMONAL SEPSIS |
114 |
0.0650 |
| 244 |
LIVER ABSCESS |
211 |
0.0650 |
| 245 |
HYDRONEPHROSIS |
481 |
0.0642 |
| 246 |
NEPHROTIC SYNDROME |
440 |
0.0641 |
| 247 |
OPTIC NEUROPATHY |
135 |
0.0637 |
| 248 |
VASCULAR PSEUDOANEURYSM |
111 |
0.0637 |
| 249 |
COVID-19 PNEUMONIA |
742 |
0.0628 |
| 250 |
SOFT TISSUE INFECTION |
115 |
0.0628 |
| 251 |
RHINOVIRUS INFECTION |
242 |
0.0621 |
| 252 |
PNEUMONIA BACTERIAL |
568 |
0.0618 |
| 253 |
RENAL TUBULAR DISORDER |
173 |
0.0614 |
| 254 |
SEPTIC SHOCK |
2658 |
0.0610 |
| 255 |
HAEMATOLOGICAL INFECTION |
144 |
0.0588 |
| 256 |
HEPATIC FIBROSIS |
202 |
0.0588 |
| 257 |
EMPYEMA |
113 |
0.0568 |
| 258 |
NEUROTOXICITY |
994 |
0.0567 |
| 259 |
VARICELLA |
135 |
0.0565 |
| 260 |
ENCEPHALITIS |
387 |
0.0559 |
| 261 |
SQUAMOUS CELL CARCINOMA |
522 |
0.0554 |
| 262 |
PATHOGEN RESISTANCE |
505 |
0.0553 |
| 263 |
LARGE INTESTINAL ULCER |
150 |
0.0552 |
| 264 |
CHOLANGITIS |
342 |
0.0551 |
| 265 |
BLOOD CREATININE ABNORMAL |
190 |
0.0549 |
| 266 |
OESOPHAGEAL CANDIDIASIS |
216 |
0.0541 |
| 267 |
PRE-ECLAMPSIA |
255 |
0.0536 |
| 268 |
STAPHYLOCOCCAL SEPSIS |
263 |
0.0532 |
| 269 |
CANDIDA INFECTION |
896 |
0.0530 |
| 270 |
CLOSTRIDIUM DIFFICILE COLITIS |
558 |
0.0526 |
| 271 |
APLASTIC ANAEMIA |
269 |
0.0515 |
| 272 |
SHOCK HAEMORRHAGIC |
419 |
0.0514 |
| 273 |
ABDOMINAL INFECTION |
131 |
0.0512 |
| 274 |
PROTEINURIA |
972 |
0.0511 |
| 275 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
180 |
0.0510 |
| 276 |
LUNG ABSCESS |
106 |
0.0505 |
| 277 |
PULMONARY ALVEOLAR HAEMORRHAGE |
283 |
0.0504 |
| 278 |
BRAIN HERNIATION |
150 |
0.0502 |
| 279 |
OESOPHAGEAL ULCER |
193 |
0.0501 |
| 280 |
OLIGURIA |
311 |
0.0500 |
| 281 |
HEPATITIS C |
600 |
0.0496 |
| 282 |
LEUKOENCEPHALOPATHY |
185 |
0.0496 |
| 283 |
OESOPHAGEAL STENOSIS |
141 |
0.0495 |
| 284 |
GRANULOMA |
168 |
0.0485 |
| 285 |
DRUG LEVEL DECREASED |
493 |
0.0484 |
| 286 |
SCLERODERMA |
176 |
0.0484 |
| 287 |
HEPATOSPLENOMEGALY |
124 |
0.0483 |
| 288 |
HEPATIC NECROSIS |
181 |
0.0480 |
| 289 |
NEPHROGENIC SYSTEMIC FIBROSIS |
145 |
0.0479 |
| 290 |
UROSEPSIS |
438 |
0.0474 |
| 291 |
OVARIAN CYST |
472 |
0.0472 |
| 292 |
B-CELL LYMPHOMA |
160 |
0.0471 |
| 293 |
WOUND DEHISCENCE |
158 |
0.0467 |
| 294 |
PORTAL VEIN THROMBOSIS |
150 |
0.0464 |
| 295 |
PNEUMONIA VIRAL |
148 |
0.0464 |
| 296 |
END STAGE RENAL DISEASE |
839 |
0.0460 |
| 297 |
BLOOD CREATININE INCREASED |
2999 |
0.0459 |
| 298 |
TOXIC ENCEPHALOPATHY |
230 |
0.0454 |
| 299 |
SKIN PAPILLOMA |
182 |
0.0453 |
| 300 |
LEUKOPENIA |
2267 |
0.0453 |
| 301 |
ENDOCARDITIS |
232 |
0.0452 |
| 302 |
LYMPHOPENIA |
636 |
0.0449 |
| 303 |
GUILLAIN-BARRE SYNDROME |
217 |
0.0448 |
| 304 |
HYPERURICAEMIA |
184 |
0.0447 |
| 305 |
HYPOALBUMINAEMIA |
348 |
0.0447 |
| 306 |
RENAL IMPAIRMENT |
3760 |
0.0447 |
| 307 |
PREMATURE DELIVERY |
711 |
0.0446 |
| 308 |
PORTAL HYPERTENSION |
136 |
0.0441 |
| 309 |
PULMONARY TUBERCULOSIS |
188 |
0.0440 |
| 310 |
NOSOCOMIAL INFECTION |
96 |
0.0435 |
| 311 |
HYPERAMMONAEMIA |
217 |
0.0433 |
| 312 |
CLOSTRIDIAL INFECTION |
146 |
0.0431 |
| 313 |
BACTERIAL INFECTION |
795 |
0.0426 |
| 314 |
STEM CELL TRANSPLANT |
106 |
0.0424 |
| 315 |
DRUG LEVEL BELOW THERAPEUTIC |
234 |
0.0424 |
| 316 |
BLOOD IMMUNOGLOBULIN G DECREASED |
105 |
0.0423 |
| 317 |
TUBULOINTERSTITIAL NEPHRITIS |
793 |
0.0423 |
| 318 |
LUNG OPACITY |
109 |
0.0413 |
| 319 |
TRANSPLANT |
98 |
0.0412 |
| 320 |
ACUTE KIDNEY INJURY |
6303 |
0.0411 |
| 321 |
DRUG INTERACTION |
6513 |
0.0410 |
| 322 |
LEFT VENTRICULAR HYPERTROPHY |
175 |
0.0408 |
| 323 |
POTENTIATING DRUG INTERACTION |
137 |
0.0408 |
| 324 |
DERMATOMYOSITIS |
103 |
0.0406 |
| 325 |
ANURIA |
349 |
0.0405 |
| 326 |
BLOOD CREATINE INCREASED |
179 |
0.0404 |
| 327 |
HEPATOCELLULAR CARCINOMA |
307 |
0.0403 |
| 328 |
DYSLIPIDAEMIA |
204 |
0.0401 |
| 329 |
NEPHROGENIC ANAEMIA |
186 |
0.0401 |
| 330 |
RESPIRATORY FAILURE |
2914 |
0.0399 |
| 331 |
FOETAL GROWTH RESTRICTION |
242 |
0.0398 |
| 332 |
ENCEPHALOPATHY |
972 |
0.0395 |
| 333 |
CUSHINGOID |
127 |
0.0395 |
| 334 |
NECROSIS |
220 |
0.0395 |
| 335 |
HAEMOLYTIC ANAEMIA |
353 |
0.0394 |
| 336 |
ENDOPHTHALMITIS |
235 |
0.0391 |
| 337 |
SERUM SICKNESS |
109 |
0.0391 |
| 338 |
ENTEROCOLITIS |
225 |
0.0389 |
| 339 |
DISSEMINATED INTRAVASCULAR COAGULATION |
548 |
0.0389 |
| 340 |
HEPATITIS B |
234 |
0.0388 |
| 341 |
HAEMODYNAMIC INSTABILITY |
289 |
0.0379 |
| 342 |
PANCYTOPENIA |
2114 |
0.0378 |
| 343 |
MULTI-ORGAN FAILURE |
643 |
0.0372 |
| 344 |
METABOLIC ENCEPHALOPATHY |
110 |
0.0366 |
| 345 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
140 |
0.0366 |
| 346 |
DRUG RESISTANCE |
941 |
0.0366 |
| 347 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
109 |
0.0362 |
| 348 |
STAPHYLOCOCCAL INFECTION |
1191 |
0.0361 |
| 349 |
AZOTAEMIA |
144 |
0.0360 |
| 350 |
HEPATITIS B REACTIVATION |
114 |
0.0359 |
| 351 |
IMMUNOSUPPRESSION |
316 |
0.0358 |
| 352 |
HYPERKALAEMIA |
1251 |
0.0356 |
| 353 |
HAEMODIALYSIS |
297 |
0.0353 |
| 354 |
NEPHROPATHY |
330 |
0.0353 |
| 355 |
LUNG TRANSPLANT |
124 |
0.0350 |
| 356 |
CYTOPENIA |
427 |
0.0348 |
| 357 |
ACUTE RESPIRATORY FAILURE |
666 |
0.0346 |
| 358 |
NEPHRITIS |
115 |
0.0344 |
| 359 |
HYPERVOLAEMIA |
170 |
0.0344 |
| 360 |
HEPATITIS CHOLESTATIC |
207 |
0.0343 |
| 361 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
302 |
0.0341 |
| 362 |
RENAL CELL CARCINOMA |
166 |
0.0339 |
| 363 |
FIBROSIS |
104 |
0.0338 |
| 364 |
LUNG ADENOCARCINOMA |
101 |
0.0335 |
| 365 |
ENTERITIS |
214 |
0.0334 |
| 366 |
SPLENOMEGALY |
385 |
0.0328 |
| 367 |
FUNGAL INFECTION |
1094 |
0.0328 |
| 368 |
POSTOPERATIVE WOUND INFECTION |
221 |
0.0327 |
| 369 |
DUODENITIS |
100 |
0.0326 |
| 370 |
SEPSIS |
3633 |
0.0325 |
| 371 |
ASCITES |
957 |
0.0325 |
| 372 |
HYPOMAGNESAEMIA |
453 |
0.0325 |
| 373 |
PROSTATITIS |
99 |
0.0325 |
| 374 |
ARTHRITIS BACTERIAL |
132 |
0.0321 |
| 375 |
FOOD ALLERGY |
247 |
0.0320 |
| 376 |
URINE OUTPUT DECREASED |
277 |
0.0317 |
| 377 |
GASTROINTESTINAL TOXICITY |
152 |
0.0316 |
| 378 |
SKIN NECROSIS |
161 |
0.0310 |
| 379 |
FAILURE TO THRIVE |
161 |
0.0310 |
| 380 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
270 |
0.0310 |
| 381 |
CHRONIC MYELOID LEUKAEMIA |
142 |
0.0307 |
| 382 |
HYPERTRIGLYCERIDAEMIA |
180 |
0.0307 |
| 383 |
PREMATURE BABY |
923 |
0.0306 |
| 384 |
HAEMOLYSIS |
234 |
0.0303 |
| 385 |
ABDOMINAL ABSCESS |
133 |
0.0301 |
| 386 |
PROTEIN URINE PRESENT |
150 |
0.0301 |
| 387 |
SUBCUTANEOUS ABSCESS |
144 |
0.0300 |
| 388 |
RENAL FAILURE CHRONIC |
231 |
0.0300 |
| 389 |
IMMUNE THROMBOCYTOPENIA |
137 |
0.0299 |
| 390 |
HEART DISEASE CONGENITAL |
104 |
0.0294 |
| 391 |
HERPES VIRUS INFECTION |
169 |
0.0293 |
| 392 |
ODYNOPHAGIA |
173 |
0.0290 |
| 393 |
LARGE INTESTINE PERFORATION |
200 |
0.0288 |
| 394 |
GASTROENTERITIS |
420 |
0.0288 |
| 395 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1573 |
0.0286 |
| 396 |
MYOPATHY |
247 |
0.0286 |
| 397 |
PULMONARY HAEMORRHAGE |
220 |
0.0281 |
| 398 |
CORONAVIRUS INFECTION |
185 |
0.0279 |
| 399 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
181 |
0.0278 |
| 400 |
HEPATIC FAILURE |
839 |
0.0278 |
| 401 |
ELECTROLYTE IMBALANCE |
323 |
0.0278 |
| 402 |
BRAIN OEDEMA |
350 |
0.0277 |
| 403 |
ATELECTASIS |
266 |
0.0275 |
| 404 |
ACIDOSIS |
210 |
0.0275 |
| 405 |
BLOOD UREA INCREASED |
459 |
0.0274 |
| 406 |
THERAPY PARTIAL RESPONDER |
426 |
0.0273 |
| 407 |
INTRACRANIAL PRESSURE INCREASED |
152 |
0.0272 |
| 408 |
BONE MARROW FAILURE |
554 |
0.0272 |
| 409 |
CANDIDIASIS |
109 |
0.0271 |
| 410 |
HYPOVOLAEMIA |
159 |
0.0271 |
| 411 |
DEVICE RELATED INFECTION |
418 |
0.0271 |
| 412 |
CATATONIA |
141 |
0.0268 |
| 413 |
LUNG INFILTRATION |
237 |
0.0268 |
| 414 |
BASAL CELL CARCINOMA |
415 |
0.0266 |
| 415 |
VIRAL LOAD INCREASED |
103 |
0.0265 |
| 416 |
CHOLESTASIS |
505 |
0.0263 |
| 417 |
BRONCHIECTASIS |
177 |
0.0262 |
| 418 |
PRODUCT USE IN UNAPPROVED INDICATION |
6480 |
0.0261 |
| 419 |
PULMONARY MASS |
389 |
0.0261 |
| 420 |
CARDIAC TAMPONADE |
124 |
0.0261 |
| 421 |
CLOSTRIDIUM DIFFICILE INFECTION |
569 |
0.0260 |
| 422 |
DISEASE RECURRENCE |
1240 |
0.0260 |
| 423 |
NEUROLOGICAL SYMPTOM |
149 |
0.0260 |
| 424 |
HYPERCALCAEMIA |
320 |
0.0259 |
| 425 |
ABSCESS LIMB |
109 |
0.0256 |
| 426 |
METASTASES TO LYMPH NODES |
170 |
0.0252 |
| 427 |
SKIN MASS |
168 |
0.0251 |
| 428 |
HYPERBILIRUBINAEMIA |
260 |
0.0251 |
| 429 |
MENINGITIS |
167 |
0.0250 |
| 430 |
PERICARDIAL EFFUSION |
576 |
0.0249 |
| 431 |
MYASTHENIA GRAVIS |
200 |
0.0247 |
| 432 |
METABOLIC ACIDOSIS |
787 |
0.0246 |
| 433 |
HYDROCEPHALUS |
133 |
0.0244 |
| 434 |
PULSELESS ELECTRICAL ACTIVITY |
100 |
0.0239 |
| 435 |
CACHEXIA |
122 |
0.0237 |
| 436 |
TOXICITY TO VARIOUS AGENTS |
3985 |
0.0236 |
| 437 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
242 |
0.0235 |
| 438 |
MUCOSAL INFLAMMATION |
611 |
0.0233 |
| 439 |
AUTOIMMUNE HEPATITIS |
162 |
0.0233 |
| 440 |
DIALYSIS |
330 |
0.0232 |
| 441 |
AGRANULOCYTOSIS |
431 |
0.0232 |
| 442 |
PLEURAL EFFUSION |
1409 |
0.0231 |
| 443 |
GLOMERULAR FILTRATION RATE DECREASED |
283 |
0.0230 |
| 444 |
PAPULE |
162 |
0.0230 |
| 445 |
COVID-19 |
4007 |
0.0228 |
| 446 |
MALNUTRITION |
255 |
0.0228 |
| 447 |
ACUTE MYELOID LEUKAEMIA |
353 |
0.0226 |
| 448 |
SKIN INFECTION |
254 |
0.0226 |
| 449 |
INFLAMMATORY MARKER INCREASED |
112 |
0.0226 |
| 450 |
ACUTE HEPATIC FAILURE |
308 |
0.0225 |
| 451 |
IRON DEFICIENCY ANAEMIA |
208 |
0.0225 |
| 452 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
357 |
0.0225 |
| 453 |
STREPTOCOCCAL INFECTION |
125 |
0.0224 |
| 454 |
RESPIRATORY DISTRESS |
618 |
0.0224 |
| 455 |
RENAL FAILURE |
2964 |
0.0223 |
| 456 |
WOUND INFECTION |
244 |
0.0223 |
| 457 |
ILEUS PARALYTIC |
99 |
0.0222 |
| 458 |
VASCULAR DEVICE INFECTION |
100 |
0.0220 |
| 459 |
SUBARACHNOID HAEMORRHAGE |
224 |
0.0220 |
| 460 |
BLOOD ALBUMIN DECREASED |
173 |
0.0218 |
| 461 |
MENTAL STATUS CHANGES |
603 |
0.0217 |
| 462 |
HYPOVOLAEMIC SHOCK |
103 |
0.0215 |
| 463 |
SKIN LESION |
587 |
0.0214 |
| 464 |
METASTASES TO LUNG |
247 |
0.0214 |
| 465 |
ARTERIOSCLEROSIS |
201 |
0.0213 |
| 466 |
INTESTINAL ISCHAEMIA |
117 |
0.0212 |
| 467 |
SERUM FERRITIN INCREASED |
112 |
0.0212 |
| 468 |
HYPERGLYCAEMIA |
773 |
0.0212 |
| 469 |
INTERSTITIAL LUNG DISEASE |
1026 |
0.0212 |
| 470 |
LUNG INFECTION |
328 |
0.0211 |
| 471 |
HYPOPHOSPHATAEMIA |
156 |
0.0211 |
| 472 |
PREMATURE LABOUR |
119 |
0.0210 |
| 473 |
FEBRILE NEUTROPENIA |
1396 |
0.0210 |
| 474 |
PANCREATITIS ACUTE |
472 |
0.0210 |
| 475 |
STATUS EPILEPTICUS |
236 |
0.0209 |
| 476 |
SHOCK |
479 |
0.0208 |
| 477 |
CARDIAC FAILURE ACUTE |
138 |
0.0207 |
| 478 |
COLITIS |
783 |
0.0206 |
| 479 |
BLOOD MAGNESIUM DECREASED |
178 |
0.0206 |
| 480 |
PNEUMOTHORAX |
327 |
0.0206 |
| 481 |
PERITONITIS |
426 |
0.0205 |
| 482 |
DIABETES MELLITUS |
1561 |
0.0205 |
| 483 |
GESTATIONAL DIABETES |
97 |
0.0203 |
| 484 |
OSTEOMYELITIS |
367 |
0.0202 |
| 485 |
OESOPHAGITIS |
221 |
0.0202 |
| 486 |
RENAL FAILURE ACUTE |
857 |
0.0202 |
| 487 |
INFLAMMATORY BOWEL DISEASE |
196 |
0.0200 |
| 488 |
MOUTH ULCERATION |
421 |
0.0200 |
| 489 |
THROMBOCYTOPENIA |
2231 |
0.0199 |
| 490 |
LEUKOCYTOSIS |
360 |
0.0199 |
| 491 |
SKIN PLAQUE |
167 |
0.0198 |
| 492 |
MYOSITIS |
177 |
0.0197 |
| 493 |
DERMATITIS ATOPIC |
1039 |
0.0197 |
| 494 |
HYPERLIPIDAEMIA |
235 |
0.0196 |
| 495 |
BLOOD POTASSIUM INCREASED |
318 |
0.0196 |
| 496 |
ANGIOPATHY |
109 |
0.0194 |
| 497 |
TRANSAMINASES INCREASED |
428 |
0.0192 |
| 498 |
COAGULOPATHY |
317 |
0.0190 |
| 499 |
GASTRIC ULCER |
361 |
0.0190 |
| 500 |
NEUTROPENIA |
2572 |
0.0189 |
| 501 |
NEUTROPENIC SEPSIS |
135 |
0.0189 |
| 502 |
VENTRICULAR SEPTAL DEFECT |
108 |
0.0188 |
| 503 |
HEPATIC FUNCTION ABNORMAL |
701 |
0.0188 |
| 504 |
MALABSORPTION |
98 |
0.0187 |
| 505 |
NORMAL NEWBORN |
102 |
0.0187 |
| 506 |
HEPATIC ENCEPHALOPATHY |
175 |
0.0187 |
| 507 |
DIABETIC KETOACIDOSIS |
448 |
0.0186 |
| 508 |
RALES |
108 |
0.0186 |
| 509 |
PLEURISY |
110 |
0.0185 |
| 510 |
DIARRHOEA HAEMORRHAGIC |
173 |
0.0185 |
| 511 |
SMALL INTESTINAL OBSTRUCTION |
227 |
0.0184 |
| 512 |
THERAPY NON-RESPONDER |
828 |
0.0184 |
| 513 |
HAEMORRHAGE INTRACRANIAL |
271 |
0.0181 |
| 514 |
OFF LABEL USE |
15788 |
0.0180 |
| 515 |
PULMONARY TOXICITY |
127 |
0.0179 |
| 516 |
RENAL DISORDER |
831 |
0.0178 |
| 517 |
METASTASIS |
127 |
0.0178 |
| 518 |
HYPOXIA |
619 |
0.0176 |
| 519 |
ORAL CANDIDIASIS |
231 |
0.0175 |
| 520 |
CHRONIC KIDNEY DISEASE |
1326 |
0.0174 |
| 521 |
RESPIRATORY TRACT INFECTION |
454 |
0.0174 |
| 522 |
VIRAL INFECTION |
579 |
0.0174 |
| 523 |
INTESTINAL PERFORATION |
195 |
0.0174 |
| 524 |
LYMPHOMA |
268 |
0.0173 |
| 525 |
DUODENAL ULCER |
122 |
0.0173 |
| 526 |
TYPE 1 DIABETES MELLITUS |
104 |
0.0172 |
| 527 |
HYPERTRANSAMINASAEMIA |
120 |
0.0172 |
| 528 |
ILEUS |
214 |
0.0172 |
| 529 |
LIVER FUNCTION TEST ABNORMAL |
498 |
0.0171 |
| 530 |
GENERALISED TONIC-CLONIC SEIZURE |
282 |
0.0170 |
| 531 |
INFECTION |
2439 |
0.0168 |
| 532 |
LYMPHADENOPATHY |
593 |
0.0167 |
| 533 |
GLUCOSE TOLERANCE IMPAIRED |
98 |
0.0166 |
| 534 |
PHOTOSENSITIVITY REACTION |
273 |
0.0165 |
| 535 |
EXPOSURE DURING PREGNANCY |
1021 |
0.0164 |
| 536 |
RETINAL HAEMORRHAGE |
117 |
0.0164 |
| 537 |
BLOOD URIC ACID INCREASED |
94 |
0.0163 |
| 538 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
276 |
0.0162 |
| 539 |
ANAEMIA |
3076 |
0.0161 |
| 540 |
GASTROINTESTINAL INFECTION |
144 |
0.0160 |
| 541 |
REBOUND EFFECT |
179 |
0.0158 |
| 542 |
HEPATIC CIRRHOSIS |
296 |
0.0157 |
| 543 |
ABSCESS |
251 |
0.0157 |
| 544 |
FLUID OVERLOAD |
228 |
0.0157 |
| 545 |
TUMOUR LYSIS SYNDROME |
137 |
0.0156 |
| 546 |
URINARY TRACT INFECTION |
2651 |
0.0155 |
| 547 |
CARDIOGENIC SHOCK |
222 |
0.0155 |
| 548 |
BLOOD BILIRUBIN INCREASED |
415 |
0.0153 |
| 549 |
MYELODYSPLASTIC SYNDROME |
222 |
0.0153 |
| 550 |
LYMPHOCYTE COUNT DECREASED |
269 |
0.0152 |
| 551 |
HEPATOMEGALY |
149 |
0.0151 |
| 552 |
HERPES ZOSTER |
871 |
0.0151 |
| 553 |
CEREBRAL INFARCTION |
369 |
0.0151 |
| 554 |
PERITONITIS BACTERIAL |
152 |
0.0150 |
| 555 |
NEUTROPHIL COUNT INCREASED |
154 |
0.0150 |
| 556 |
GENERALISED OEDEMA |
186 |
0.0150 |
| 557 |
POLYURIA |
123 |
0.0150 |
| 558 |
APHTHOUS ULCER |
115 |
0.0148 |
| 559 |
HEPATOTOXICITY |
329 |
0.0148 |
| 560 |
ORAL DISORDER |
107 |
0.0146 |
| 561 |
HAEMATURIA |
499 |
0.0146 |
| 562 |
HEMIPARESIS |
246 |
0.0145 |
| 563 |
PNEUMONIA |
4683 |
0.0145 |
| 564 |
PYREXIA |
4949 |
0.0143 |
| 565 |
HAEMATOCRIT DECREASED |
283 |
0.0143 |
| 566 |
SKIN CANCER |
306 |
0.0142 |
| 567 |
TACHYPNOEA |
193 |
0.0142 |
| 568 |
ADRENAL INSUFFICIENCY |
171 |
0.0141 |
| 569 |
ECZEMA |
731 |
0.0140 |
| 570 |
TREATMENT FAILURE |
1155 |
0.0139 |
| 571 |
MATERNAL EXPOSURE DURING PREGNANCY |
1242 |
0.0139 |
| 572 |
PNEUMONITIS |
378 |
0.0139 |
| 573 |
MITRAL VALVE INCOMPETENCE |
155 |
0.0137 |
| 574 |
RENAL CYST |
108 |
0.0136 |
| 575 |
SKIN ULCER |
351 |
0.0136 |
| 576 |
SPINAL COMPRESSION FRACTURE |
112 |
0.0135 |
| 577 |
DRUG TOXICITY |
184 |
0.0135 |
| 578 |
C-REACTIVE PROTEIN INCREASED |
489 |
0.0134 |
| 579 |
ALTERED STATE OF CONSCIOUSNESS |
287 |
0.0132 |
| 580 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
328 |
0.0132 |
| 581 |
VISUAL FIELD DEFECT |
95 |
0.0131 |
| 582 |
MALIGNANT MELANOMA |
176 |
0.0131 |
| 583 |
CENTRAL NERVOUS SYSTEM LESION |
180 |
0.0131 |
| 584 |
SKIN HYPERPIGMENTATION |
112 |
0.0130 |
| 585 |
MYOCLONUS |
155 |
0.0130 |
| 586 |
CEREBRAL HAEMORRHAGE |
465 |
0.0130 |
| 587 |
PULMONARY HYPERTENSION |
270 |
0.0129 |
| 588 |
POST PROCEDURAL COMPLICATION |
248 |
0.0129 |
| 589 |
MYOCARDITIS |
148 |
0.0129 |
| 590 |
ORAL HERPES |
252 |
0.0129 |
| 591 |
FACIAL PARALYSIS |
110 |
0.0129 |
| 592 |
FOETAL EXPOSURE DURING PREGNANCY |
1048 |
0.0129 |
| 593 |
TREATMENT NONCOMPLIANCE |
701 |
0.0128 |
| 594 |
ABORTION INDUCED |
120 |
0.0127 |
| 595 |
VASCULITIS |
148 |
0.0127 |
| 596 |
CELLULITIS |
637 |
0.0126 |
| 597 |
HYPONATRAEMIA |
712 |
0.0126 |
| 598 |
PNEUMONIA ASPIRATION |
313 |
0.0125 |
| 599 |
HAEMATOMA |
321 |
0.0124 |
| 600 |
JAUNDICE |
329 |
0.0122 |
| 601 |
HAEMATOTOXICITY |
116 |
0.0122 |
| 602 |
PULMONARY OEDEMA |
544 |
0.0121 |
| 603 |
CARDIOMEGALY |
148 |
0.0120 |
| 604 |
LIVER DISORDER |
533 |
0.0120 |
| 605 |
KIDNEY INFECTION |
235 |
0.0120 |
| 606 |
CARDIOMYOPATHY |
175 |
0.0118 |
| 607 |
CARDIAC ARREST |
971 |
0.0117 |
| 608 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
260 |
0.0117 |
| 609 |
MELAENA |
257 |
0.0117 |
| 610 |
METASTASES TO LIVER |
205 |
0.0117 |
| 611 |
SKIN HAEMORRHAGE |
172 |
0.0116 |
| 612 |
SKIN FISSURES |
226 |
0.0116 |
| 613 |
HAEMOGLOBIN DECREASED |
1183 |
0.0115 |
| 614 |
HAEMOPTYSIS |
320 |
0.0115 |
| 615 |
HYPERTENSION |
2427 |
0.0114 |
| 616 |
MYOCARDIAL ISCHAEMIA |
130 |
0.0114 |
| 617 |
HYPOCALCAEMIA |
216 |
0.0114 |
| 618 |
COLITIS ULCERATIVE |
506 |
0.0113 |
| 619 |
ULCER |
180 |
0.0113 |
| 620 |
ATAXIA |
134 |
0.0113 |
| 621 |
DERMATITIS |
235 |
0.0112 |
| 622 |
HEPATITIS |
286 |
0.0112 |
| 623 |
IMMUNE SYSTEM DISORDER |
147 |
0.0111 |
| 624 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
325 |
0.0111 |
| 625 |
CAESAREAN SECTION |
129 |
0.0111 |
| 626 |
IMMUNODEFICIENCY |
163 |
0.0109 |
| 627 |
ALANINE AMINOTRANSFERASE INCREASED |
671 |
0.0109 |
| 628 |
ABORTION SPONTANEOUS |
437 |
0.0109 |
| 629 |
MASS |
152 |
0.0109 |
| 630 |
SUPRAVENTRICULAR TACHYCARDIA |
104 |
0.0109 |
| 631 |
DRUG-INDUCED LIVER INJURY |
340 |
0.0108 |
| 632 |
TREMOR |
1795 |
0.0108 |
| 633 |
INTRAOCULAR PRESSURE INCREASED |
138 |
0.0108 |
| 634 |
INTENTIONAL PRODUCT USE ISSUE |
942 |
0.0107 |
| 635 |
HEPATIC STEATOSIS |
200 |
0.0107 |
| 636 |
UPPER RESPIRATORY TRACT INFECTION |
496 |
0.0107 |
| 637 |
CONDITION AGGRAVATED |
3249 |
0.0107 |
| 638 |
NO THERAPEUTIC RESPONSE |
130 |
0.0107 |
| 639 |
EOSINOPHILIA |
186 |
0.0106 |
| 640 |
APPENDICITIS |
99 |
0.0106 |
| 641 |
CIRCULATORY COLLAPSE |
178 |
0.0104 |
| 642 |
GASTRITIS |
274 |
0.0104 |
| 643 |
UVEITIS |
141 |
0.0104 |
| 644 |
RENAL INJURY |
307 |
0.0103 |
| 645 |
CHOLECYSTITIS |
123 |
0.0103 |
| 646 |
MYELOSUPPRESSION |
369 |
0.0102 |
| 647 |
CONJUNCTIVITIS |
190 |
0.0102 |
| 648 |
GASTROINTESTINAL HAEMORRHAGE |
853 |
0.0102 |
| 649 |
OSTEONECROSIS |
335 |
0.0102 |
| 650 |
PREGNANCY |
204 |
0.0102 |
| 651 |
HEPATOCELLULAR INJURY |
144 |
0.0101 |
| 652 |
ASPARTATE AMINOTRANSFERASE INCREASED |
538 |
0.0101 |
| 653 |
DISEASE PROGRESSION |
1197 |
0.0101 |
| 654 |
DELIRIUM |
351 |
0.0101 |
| 655 |
ANOREXIA |
130 |
0.0101 |
| 656 |
HYPERCHOLESTEROLAEMIA |
97 |
0.0100 |
| 657 |
GASTROINTESTINAL DISORDER |
893 |
0.0100 |
| 658 |
FISTULA |
112 |
0.0100 |
| 659 |
RESPIRATORY DISORDER |
298 |
0.0100 |
| 660 |
CARDIAC FAILURE |
799 |
0.0099 |
| 661 |
GOUT |
174 |
0.0097 |
| 662 |
OEDEMA |
525 |
0.0097 |
| 663 |
METASTASES TO BONE |
158 |
0.0096 |
| 664 |
VENTRICULAR FIBRILLATION |
106 |
0.0095 |
| 665 |
NERVOUS SYSTEM DISORDER |
297 |
0.0095 |
| 666 |
DYSURIA |
349 |
0.0095 |
| 667 |
CYTOKINE RELEASE SYNDROME |
190 |
0.0095 |
| 668 |
HYPOPHAGIA |
241 |
0.0094 |
| 669 |
PRODUCT PRESCRIBING ISSUE |
205 |
0.0094 |
| 670 |
TENDERNESS |
98 |
0.0094 |
| 671 |
DIARRHOEA |
6064 |
0.0094 |
| 672 |
INFLAMMATION |
484 |
0.0094 |
| 673 |
APHASIA |
283 |
0.0094 |
| 674 |
OBSTRUCTIVE AIRWAYS DISORDER |
104 |
0.0093 |
| 675 |
LUNG DISORDER |
458 |
0.0093 |
| 676 |
HEPATIC CYTOLYSIS |
119 |
0.0093 |
| 677 |
PULMONARY FIBROSIS |
177 |
0.0092 |
| 678 |
RASH MACULO-PAPULAR |
205 |
0.0092 |
| 679 |
DRUG INTOLERANCE |
887 |
0.0092 |
| 680 |
DEHYDRATION |
1217 |
0.0091 |
| 681 |
IMPAIRED HEALING |
297 |
0.0090 |
| 682 |
LIVER FUNCTION TEST INCREASED |
194 |
0.0090 |
| 683 |
THERAPEUTIC RESPONSE DECREASED |
547 |
0.0090 |
| 684 |
ASPIRATION |
98 |
0.0089 |
| 685 |
LACTIC ACIDOSIS |
289 |
0.0089 |
| 686 |
VENTRICULAR TACHYCARDIA |
147 |
0.0089 |
| 687 |
PLATELET COUNT DECREASED |
946 |
0.0089 |
| 688 |
ELECTROCARDIOGRAM QT PROLONGED |
315 |
0.0087 |
| 689 |
COMA |
417 |
0.0087 |
| 690 |
SCAB |
99 |
0.0087 |
| 691 |
DEEP VEIN THROMBOSIS |
562 |
0.0086 |
| 692 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
145 |
0.0086 |
| 693 |
BLOOD TRIGLYCERIDES INCREASED |
152 |
0.0086 |
| 694 |
HEPATIC ENZYME INCREASED |
586 |
0.0086 |
| 695 |
ISCHAEMIC STROKE |
153 |
0.0086 |
| 696 |
LIVER INJURY |
210 |
0.0085 |
| 697 |
DIVERTICULITIS |
236 |
0.0085 |
| 698 |
ABDOMINAL PAIN |
1978 |
0.0085 |
| 699 |
RED BLOOD CELL COUNT DECREASED |
243 |
0.0085 |
| 700 |
PHARYNGITIS |
105 |
0.0085 |
| 701 |
STOMATITIS |
513 |
0.0085 |
| 702 |
PRODUCT USE ISSUE |
1579 |
0.0084 |
| 703 |
IMPAIRED GASTRIC EMPTYING |
114 |
0.0084 |
| 704 |
PULMONARY CONGESTION |
110 |
0.0083 |
| 705 |
NODULE |
108 |
0.0083 |
| 706 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
327 |
0.0083 |
| 707 |
SINUS TACHYCARDIA |
117 |
0.0082 |
| 708 |
WHITE BLOOD CELL COUNT INCREASED |
316 |
0.0082 |
| 709 |
BLOOD SODIUM DECREASED |
155 |
0.0082 |
| 710 |
PANCREATITIS |
434 |
0.0082 |
| 711 |
POST PROCEDURAL HAEMORRHAGE |
95 |
0.0082 |
| 712 |
HAEMORRHOIDS |
159 |
0.0081 |
| 713 |
HOSPITALISATION |
1251 |
0.0081 |
| 714 |
CYSTITIS |
258 |
0.0081 |
| 715 |
DRUG INEFFECTIVE |
10578 |
0.0080 |
| 716 |
DIPLOPIA |
207 |
0.0080 |
| 717 |
ACUTE MYOCARDIAL INFARCTION |
234 |
0.0079 |
| 718 |
POLYNEUROPATHY |
95 |
0.0079 |
| 719 |
GASTROENTERITIS VIRAL |
143 |
0.0079 |
| 720 |
SUBDURAL HAEMATOMA |
113 |
0.0079 |
| 721 |
HALLUCINATION, VISUAL |
166 |
0.0079 |
| 722 |
TACHYCARDIA |
693 |
0.0078 |
| 723 |
PARALYSIS |
111 |
0.0077 |
| 724 |
OSTEOPENIA |
117 |
0.0077 |
| 725 |
PRODUCTIVE COUGH |
368 |
0.0077 |
| 726 |
EPILEPSY |
235 |
0.0077 |
| 727 |
PERICARDITIS |
129 |
0.0077 |
| 728 |
SKIN EXFOLIATION |
647 |
0.0077 |
| 729 |
MUSCLE ATROPHY |
97 |
0.0076 |
| 730 |
HYPOKALAEMIA |
352 |
0.0076 |
| 731 |
CONVULSION |
434 |
0.0076 |
| 732 |
OEDEMA PERIPHERAL |
921 |
0.0075 |
| 733 |
OSTEOPOROSIS |
310 |
0.0075 |
| 734 |
INTESTINAL OBSTRUCTION |
283 |
0.0075 |
| 735 |
ACNE |
568 |
0.0075 |
| 736 |
COLON CANCER |
111 |
0.0074 |
| 737 |
DYSPNOEA EXERTIONAL |
280 |
0.0074 |
| 738 |
TOXIC EPIDERMAL NECROLYSIS |
112 |
0.0074 |
| 739 |
GENERAL PHYSICAL HEALTH DETERIORATION |
852 |
0.0074 |
| 740 |
DRUG EXPOSURE DURING PREGNANCY |
250 |
0.0073 |
| 741 |
CARDIO-RESPIRATORY ARREST |
305 |
0.0073 |
| 742 |
PSYCHOTIC DISORDER |
215 |
0.0073 |
| 743 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
257 |
0.0072 |
| 744 |
ATRIAL FIBRILLATION |
702 |
0.0072 |
| 745 |
VISUAL ACUITY REDUCED |
237 |
0.0071 |
| 746 |
HYPOTHYROIDISM |
226 |
0.0071 |
| 747 |
INFLUENZA |
785 |
0.0070 |
| 748 |
PULMONARY EMBOLISM |
668 |
0.0070 |
| 749 |
BLOOD PRESSURE SYSTOLIC INCREASED |
137 |
0.0070 |
| 750 |
HYPOTENSION |
1395 |
0.0069 |
| 751 |
BLINDNESS |
278 |
0.0068 |
| 752 |
SEIZURE |
787 |
0.0068 |
| 753 |
CORONARY ARTERY DISEASE |
206 |
0.0068 |
| 754 |
DYSARTHRIA |
253 |
0.0067 |
| 755 |
NEOPLASM MALIGNANT |
446 |
0.0067 |
| 756 |
HAEMATOCHEZIA |
368 |
0.0067 |
| 757 |
DRUG ERUPTION |
118 |
0.0067 |
| 758 |
VOMITING |
3091 |
0.0066 |
| 759 |
PRESCRIBED UNDERDOSE |
131 |
0.0066 |
| 760 |
THROMBOSIS |
528 |
0.0066 |
| 761 |
WHITE BLOOD CELL COUNT DECREASED |
711 |
0.0066 |
| 762 |
BODY TEMPERATURE INCREASED |
133 |
0.0065 |
| 763 |
DRY EYE |
325 |
0.0065 |
| 764 |
DIABETES MELLITUS INADEQUATE CONTROL |
114 |
0.0064 |
| 765 |
RASH ERYTHEMATOUS |
307 |
0.0064 |
| 766 |
RHABDOMYOLYSIS |
267 |
0.0064 |
| 767 |
URINARY RETENTION |
212 |
0.0063 |
| 768 |
CHILLS |
742 |
0.0063 |
| 769 |
LOCALISED INFECTION |
152 |
0.0063 |
| 770 |
ABDOMINAL PAIN LOWER |
158 |
0.0062 |
| 771 |
FLUID RETENTION |
317 |
0.0062 |
| 772 |
WEIGHT DECREASED |
1735 |
0.0062 |
| 773 |
DRY SKIN |
828 |
0.0062 |
| 774 |
LABORATORY TEST ABNORMAL |
183 |
0.0062 |
| 775 |
DISCOMFORT |
377 |
0.0062 |
| 776 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
439 |
0.0062 |
| 777 |
PHOTOPHOBIA |
116 |
0.0062 |
| 778 |
DRUG DISPENSING ERROR |
94 |
0.0061 |
| 779 |
UNRESPONSIVE TO STIMULI |
154 |
0.0060 |
| 780 |
DISORIENTATION |
236 |
0.0059 |
| 781 |
DEATH |
5120 |
0.0059 |
| 782 |
SKIN DISORDER |
197 |
0.0059 |
| 783 |
CONFUSIONAL STATE |
954 |
0.0059 |
| 784 |
DYSPHAGIA |
551 |
0.0058 |
| 785 |
PRODUCT PRESCRIBING ERROR |
138 |
0.0058 |
| 786 |
BLOOD PRESSURE FLUCTUATION |
139 |
0.0058 |
| 787 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
99 |
0.0058 |
| 788 |
SCAR |
98 |
0.0057 |
| 789 |
HAEMORRHAGE |
598 |
0.0057 |
| 790 |
CHOLELITHIASIS |
187 |
0.0057 |
| 791 |
NEUTROPHIL COUNT DECREASED |
232 |
0.0057 |
| 792 |
NEPHROLITHIASIS |
259 |
0.0056 |
| 793 |
COUGH |
1581 |
0.0056 |
| 794 |
LOWER RESPIRATORY TRACT INFECTION |
256 |
0.0056 |
| 795 |
OXYGEN SATURATION DECREASED |
316 |
0.0056 |
| 796 |
RASH PAPULAR |
125 |
0.0056 |
| 797 |
ALOPECIA |
1093 |
0.0056 |
| 798 |
DECREASED APPETITE |
1292 |
0.0056 |
| 799 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
266 |
0.0055 |
| 800 |
PRURITUS |
2108 |
0.0055 |
| 801 |
PLASMA CELL MYELOMA |
214 |
0.0055 |
| 802 |
HAEMATEMESIS |
139 |
0.0055 |
| 803 |
CATARACT |
323 |
0.0054 |
| 804 |
RESTLESS LEGS SYNDROME |
97 |
0.0053 |
| 805 |
TYPE 2 DIABETES MELLITUS |
178 |
0.0053 |
| 806 |
NEUROPATHY PERIPHERAL |
501 |
0.0053 |
| 807 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
132 |
0.0052 |
| 808 |
FRACTURE |
99 |
0.0052 |
| 809 |
INTERNATIONAL NORMALISED RATIO INCREASED |
149 |
0.0052 |
| 810 |
BRADYCARDIA |
277 |
0.0052 |
| 811 |
THERAPEUTIC RESPONSE SHORTENED |
173 |
0.0052 |
| 812 |
ANAPHYLACTIC REACTION |
286 |
0.0052 |
| 813 |
EYE PAIN |
292 |
0.0052 |
| 814 |
RASH |
2255 |
0.0052 |
| 815 |
EYE PRURITUS |
173 |
0.0051 |
| 816 |
MUSCULAR WEAKNESS |
578 |
0.0051 |
| 817 |
SLEEP APNOEA SYNDROME |
97 |
0.0051 |
| 818 |
SURGERY |
297 |
0.0051 |
| 819 |
RASH MACULAR |
177 |
0.0051 |
| 820 |
HYPOGLYCAEMIA |
243 |
0.0050 |
| 821 |
ERYTHEMA |
1029 |
0.0050 |
| 822 |
BRONCHITIS |
370 |
0.0050 |
| 823 |
NIGHT SWEATS |
160 |
0.0050 |
| 824 |
LUNG NEOPLASM MALIGNANT |
204 |
0.0050 |
| 825 |
ACCIDENTAL OVERDOSE |
178 |
0.0049 |
| 826 |
ANGINA PECTORIS |
139 |
0.0048 |
| 827 |
CARDIOVASCULAR DISORDER |
123 |
0.0048 |
| 828 |
LETHARGY |
272 |
0.0047 |
| 829 |
RESPIRATORY ARREST |
130 |
0.0047 |
| 830 |
SLEEP DISORDER |
332 |
0.0047 |
| 831 |
ASTHENIA |
1742 |
0.0046 |
| 832 |
BLOOD PRESSURE INCREASED |
701 |
0.0046 |
| 833 |
ABDOMINAL DISTENSION |
478 |
0.0046 |
| 834 |
ARRHYTHMIA |
216 |
0.0046 |
| 835 |
OCULAR HYPERAEMIA |
216 |
0.0045 |
| 836 |
DYSPNOEA |
2565 |
0.0045 |
| 837 |
LIMB INJURY |
123 |
0.0045 |
| 838 |
SINUSITIS |
460 |
0.0045 |
| 839 |
RASH PRURITIC |
243 |
0.0045 |
| 840 |
EYE DISORDER |
147 |
0.0045 |
| 841 |
BLOOD POTASSIUM DECREASED |
134 |
0.0045 |
| 842 |
GASTROOESOPHAGEAL REFLUX DISEASE |
354 |
0.0044 |
| 843 |
CARDIAC FAILURE CONGESTIVE |
350 |
0.0044 |
| 844 |
EYE IRRITATION |
249 |
0.0043 |
| 845 |
BLOOD PRESSURE DECREASED |
287 |
0.0043 |
| 846 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
123 |
0.0043 |
| 847 |
SKIN DISCOLOURATION |
196 |
0.0043 |
| 848 |
NAUSEA |
3375 |
0.0043 |
| 849 |
HEADACHE |
2645 |
0.0042 |
| 850 |
SWELLING |
394 |
0.0042 |
| 851 |
PRODUCT AVAILABILITY ISSUE |
95 |
0.0042 |
| 852 |
ANGIOEDEMA |
183 |
0.0041 |
| 853 |
MENTAL DISORDER |
178 |
0.0041 |
| 854 |
COGNITIVE DISORDER |
188 |
0.0040 |
| 855 |
ABDOMINAL PAIN UPPER |
828 |
0.0040 |
| 856 |
EAR INFECTION |
106 |
0.0040 |
| 857 |
CHEST PAIN |
736 |
0.0040 |
| 858 |
MYALGIA |
674 |
0.0040 |
| 859 |
SWELLING FACE |
258 |
0.0040 |
| 860 |
PRODUCT DOSE OMISSION IN ERROR |
112 |
0.0040 |
| 861 |
NEURALGIA |
96 |
0.0039 |
| 862 |
PALLOR |
107 |
0.0039 |
| 863 |
WEIGHT INCREASED |
869 |
0.0039 |
| 864 |
VISUAL IMPAIRMENT |
477 |
0.0038 |
| 865 |
WOUND |
107 |
0.0038 |
| 866 |
AMNESIA |
247 |
0.0038 |
| 867 |
BLISTER |
213 |
0.0038 |
| 868 |
URINARY INCONTINENCE |
112 |
0.0038 |
| 869 |
THERAPY INTERRUPTED |
270 |
0.0038 |
| 870 |
VERTIGO |
230 |
0.0038 |
| 871 |
BLOOD GLUCOSE INCREASED |
707 |
0.0037 |
| 872 |
ABDOMINAL DISCOMFORT |
627 |
0.0037 |
| 873 |
BLOOD CHOLESTEROL INCREASED |
173 |
0.0037 |
| 874 |
GASTRIC CANCER |
94 |
0.0037 |
| 875 |
MALAISE |
1599 |
0.0036 |
| 876 |
OROPHARYNGEAL PAIN |
337 |
0.0036 |
| 877 |
AGITATION |
267 |
0.0036 |
| 878 |
VISION BLURRED |
492 |
0.0036 |
| 879 |
PAIN OF SKIN |
96 |
0.0036 |
| 880 |
FEMUR FRACTURE |
110 |
0.0035 |
| 881 |
RHEUMATOID ARTHRITIS |
402 |
0.0035 |
| 882 |
OVERDOSE |
763 |
0.0035 |
| 883 |
POLLAKIURIA |
146 |
0.0035 |
| 884 |
INFUSION RELATED REACTION |
232 |
0.0035 |
| 885 |
CEREBROVASCULAR ACCIDENT |
591 |
0.0035 |
| 886 |
PERIPHERAL SWELLING |
536 |
0.0035 |
| 887 |
TRANSIENT ISCHAEMIC ATTACK |
117 |
0.0035 |
| 888 |
DYSPEPSIA |
339 |
0.0034 |
| 889 |
RESTLESSNESS |
126 |
0.0034 |
| 890 |
MEDICATION ERROR |
191 |
0.0034 |
| 891 |
EPISTAXIS |
255 |
0.0034 |
| 892 |
RHINORRHOEA |
220 |
0.0034 |
| 893 |
PSORIASIS |
440 |
0.0034 |
| 894 |
LOSS OF CONSCIOUSNESS |
429 |
0.0033 |
| 895 |
HEART RATE INCREASED |
330 |
0.0033 |
| 896 |
THERAPY CESSATION |
170 |
0.0033 |
| 897 |
BURNING SENSATION |
229 |
0.0033 |
| 898 |
FATIGUE |
2530 |
0.0032 |
| 899 |
RECTAL HAEMORRHAGE |
139 |
0.0032 |
| 900 |
MOVEMENT DISORDER |
102 |
0.0032 |
| 901 |
BACK PAIN |
736 |
0.0032 |
| 902 |
NASOPHARYNGITIS |
582 |
0.0032 |
| 903 |
CONTUSION |
301 |
0.0031 |
| 904 |
GAIT DISTURBANCE |
597 |
0.0031 |
| 905 |
HALLUCINATION |
234 |
0.0031 |
| 906 |
ARTHRALGIA |
1272 |
0.0031 |
| 907 |
SPEECH DISORDER |
160 |
0.0031 |
| 908 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
547 |
0.0030 |
| 909 |
BONE PAIN |
177 |
0.0030 |
| 910 |
CARDIAC DISORDER |
282 |
0.0030 |
| 911 |
MYOCARDIAL INFARCTION |
515 |
0.0029 |
| 912 |
CONSTIPATION |
640 |
0.0029 |
| 913 |
ADVERSE DRUG REACTION |
260 |
0.0029 |
| 914 |
SKIN IRRITATION |
132 |
0.0029 |
| 915 |
GAIT INABILITY |
96 |
0.0029 |
| 916 |
INSOMNIA |
763 |
0.0029 |
| 917 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
128 |
0.0029 |
| 918 |
GASTRIC DISORDER |
98 |
0.0029 |
| 919 |
LIP SWELLING |
95 |
0.0028 |
| 920 |
PRODUCT DOSE OMISSION ISSUE |
836 |
0.0028 |
| 921 |
FALL |
946 |
0.0028 |
| 922 |
ARTHRITIS |
222 |
0.0028 |
| 923 |
NEOPLASM PROGRESSION |
98 |
0.0028 |
| 924 |
MUSCULOSKELETAL PAIN |
147 |
0.0028 |
| 925 |
PAIN |
1720 |
0.0028 |
| 926 |
PRODUCT SUBSTITUTION ISSUE |
161 |
0.0028 |
| 927 |
OSTEOARTHRITIS |
118 |
0.0028 |
| 928 |
CHEST DISCOMFORT |
284 |
0.0028 |
| 929 |
SYNCOPE |
276 |
0.0028 |
| 930 |
NASAL CONGESTION |
162 |
0.0028 |
| 931 |
PAIN IN EXTREMITY |
809 |
0.0027 |
| 932 |
DEPRESSED MOOD |
144 |
0.0027 |
| 933 |
EYE SWELLING |
101 |
0.0027 |
| 934 |
DEPRESSION |
612 |
0.0027 |
| 935 |
UNEVALUABLE EVENT |
202 |
0.0027 |
| 936 |
URTICARIA |
440 |
0.0026 |
| 937 |
ILLNESS |
270 |
0.0026 |
| 938 |
DYSKINESIA |
106 |
0.0026 |
| 939 |
INTENTIONAL PRODUCT MISUSE |
228 |
0.0026 |
| 940 |
HYPOAESTHESIA |
386 |
0.0026 |
| 941 |
ASTHMA |
290 |
0.0026 |
| 942 |
ILL-DEFINED DISORDER |
154 |
0.0025 |
| 943 |
PARAESTHESIA |
398 |
0.0025 |
| 944 |
AGGRESSION |
126 |
0.0025 |
| 945 |
MEMORY IMPAIRMENT |
345 |
0.0025 |
| 946 |
PALPITATIONS |
293 |
0.0025 |
| 947 |
SOMNOLENCE |
496 |
0.0025 |
| 948 |
MUSCULOSKELETAL STIFFNESS |
214 |
0.0024 |
| 949 |
MIGRAINE |
227 |
0.0024 |
| 950 |
MUSCLE SPASMS |
426 |
0.0023 |
| 951 |
DIZZINESS |
1150 |
0.0023 |
| 952 |
ROAD TRAFFIC ACCIDENT |
96 |
0.0023 |
| 953 |
INCORRECT DOSE ADMINISTERED |
523 |
0.0023 |
| 954 |
ANXIETY |
648 |
0.0023 |
| 955 |
DRY MOUTH |
184 |
0.0023 |
| 956 |
INFLUENZA LIKE ILLNESS |
185 |
0.0022 |
| 957 |
BALANCE DISORDER |
193 |
0.0022 |
| 958 |
DYSPHONIA |
130 |
0.0022 |
| 959 |
BLOOD GLUCOSE DECREASED |
106 |
0.0022 |
| 960 |
DISTURBANCE IN ATTENTION |
119 |
0.0022 |
| 961 |
SKIN BURNING SENSATION |
158 |
0.0022 |
| 962 |
FLATULENCE |
125 |
0.0022 |
| 963 |
WHEEZING |
130 |
0.0022 |
| 964 |
TINNITUS |
100 |
0.0022 |
| 965 |
HYPERSENSITIVITY |
404 |
0.0022 |
| 966 |
THERAPEUTIC RESPONSE UNEXPECTED |
97 |
0.0022 |
| 967 |
FEELING HOT |
132 |
0.0022 |
| 968 |
IRRITABILITY |
127 |
0.0021 |
| 969 |
MALIGNANT NEOPLASM PROGRESSION |
215 |
0.0021 |
| 970 |
HYPERHIDROSIS |
263 |
0.0020 |
| 971 |
MOBILITY DECREASED |
146 |
0.0020 |
| 972 |
DYSGEUSIA |
145 |
0.0019 |
| 973 |
NO ADVERSE EVENT |
349 |
0.0019 |
| 974 |
JOINT SWELLING |
231 |
0.0019 |
| 975 |
NECK PAIN |
106 |
0.0019 |
| 976 |
INJURY |
128 |
0.0018 |
| 977 |
PRODUCT DOSE OMISSION |
118 |
0.0018 |
| 978 |
INJECTION SITE SWELLING |
136 |
0.0018 |
| 979 |
ARTHROPATHY |
96 |
0.0017 |
| 980 |
ADVERSE EVENT |
159 |
0.0017 |
| 981 |
FEELING ABNORMAL |
395 |
0.0016 |
| 982 |
INJECTION SITE PAIN |
491 |
0.0016 |
| 983 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
109 |
0.0015 |
| 984 |
PROSTATE CANCER |
118 |
0.0015 |
| 985 |
SUICIDAL IDEATION |
133 |
0.0015 |
| 986 |
FLUSHING |
146 |
0.0014 |
| 987 |
EMOTIONAL DISTRESS |
165 |
0.0014 |
| 988 |
ACCIDENTAL EXPOSURE TO PRODUCT |
136 |
0.0013 |
| 989 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
232 |
0.0011 |
| 990 |
DRUG DOSE OMISSION |
188 |
0.0011 |
| 991 |
INJECTION SITE ERYTHEMA |
129 |
0.0010 |
| 992 |
PRODUCT QUALITY ISSUE |
140 |
0.0010 |